Scarica l'app Stockscreener
1.38
2.13%
-0.03
Dopo l'orario di chiusura:
1.39
0.01
+0.72%
Precedente Chiudi:
$1.41
Aprire:
$1.37
Volume 24 ore:
353.44K
Relative Volume:
0.36
Capitalizzazione di mercato:
$9.69M
Reddito:
$5.75M
Utile/perdita netta:
$-38.96M
Rapporto P/E:
-0.1107
EPS:
-12.47
Flusso di cassa netto:
$-32.63M
1 W Prestazione:
-10.97%
1M Prestazione:
-92.47%
6M Prestazione:
-60.23%
1 anno Prestazione:
-73.76%
Intervallo 1D:
$1.36
$1.4168
Intervallo di 1 settimana:
$1.355
$1.55
Portata 52W:
$1.10
$20.60
Kala Bio Inc Stock (KALA) Company Profile
Nome
Kala Bio Inc
Settore
Industria
Telefono
781-996-5252
Indirizzo
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Confronta KALA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
1.38 | 10.60M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | Iniziato | Mizuho | Outperform |
| 2025-07-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-03-30 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-07-23 | Iniziato | Northland Capital | Outperform |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2020-05-27 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Kala Bio Inc Borsa (KALA) Ultime notizie
Volume spikes in KALA BIO Inc. stock – what they meanOil Prices & Weekly Watchlist of Top Performers - newser.com
Is KALA BIO Inc. stock a contrarian buyTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com
Is KALA BIO Inc. stock supported by strong cash flowsMarket Growth Report & Comprehensive Market Scan Reports - newser.com
Intraday pattern recognizer results for KALA BIO Inc.Weekly Earnings Recap & Proven Capital Preservation Tips - newser.com
Using fundamentals and technicals on KALA BIO Inc.July 2025 Breakouts & Safe Entry Point Identification - newser.com
How supply chain issues affect KALA BIO Inc. stockJuly 2025 Earnings & Daily Market Momentum Tracking - newser.com
What to expect from KALA BIO Inc. in the next 30 daysWeekly Trading Summary & Advanced Swing Trade Entry Alerts - newser.com
How sentiment analysis helps forecast KALA BIO Inc.Trend Reversal & Daily Momentum Trading Reports - newser.com
How hedge fund analytics apply to KALA BIO Inc. stockJuly 2025 Final Week & Capital Protection Trading Alerts - newser.com
KALA BIO Inc. stock prediction for this weekPortfolio Growth Summary & Low Risk Growth Stock Ideas - newser.com
Custom watchlist performance reports with KALA BIO Inc.CEO Change & Verified Short-Term Plans - newser.com
BAKER BROS. ADVISORS LP Increases Stake in Kala Bio Inc. - GuruFocus
KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure - The Globe and Mail
Is KALA BIO Inc a good long term investmentStock Rotation Strategies & Turn Market Volatility into Wealth - earlytimes.in
Is KALA BIO Inc. meeting your algorithmic filter criteria2025 Top Decliners & Verified Stock Trade Ideas - newser.com
Quantitative breakdown of KALA BIO Inc. recent moveWeekly Investment Recap & Weekly Top Stock Performers List - newser.com
Forecasting KALA BIO Inc. price range with options dataJuly 2025 Retail & Technical Pattern Alert System - newser.com
Candlestick signals on KALA BIO Inc. stock todayWeekly Stock Recap & Real-Time Volume Analysis - newser.com
Mizuho Securities Downgrades KALA BIO(KALA.US) to Hold Rating, Cuts Target Price to $1.5 - 富途牛牛
Leadership watch: KALA BIO names new CEO, Aurion Biotech promotes execs - Eyes On Eyecare
Can KALA BIO Inc. stock surprise with earnings upsideNew Guidance & Safe Entry Momentum Tips - newser.com
Q3 Earnings Estimate for KALA BIO Issued By Lifesci Capital - Defense World
Published on: 2025-10-01 09:01:05 - newser.com
Kala Bio receives notice of event of default from Oxford Finance LLCSEC filing - MarketScreener
Kala Bio receives default notice, $29.1 million loan declared immediately due - Investing.com India
Kala Bio receives default notice, $29.1 million loan declared immediately due By Investing.com - Investing.com South Africa
KALA BIO, Inc. Receives Default Notice from Oxford Finance with Respect to Certain Loan and Security Agreement - MarketScreener
KALA BIO (NASDAQ:KALA) Rating Lowered to “Hold” at Lifesci Capital - Defense World
KALA BIO, Inc. Securities Lawsuit Investigation - Claim Depot
Kala Bio Shares Fall After Downgrade From Mizuho - MarketScreener
A Heavy Trading Day Sends Biotech And Finance Stocks Reeling - Finimize
Kala Bio Faces Diminishing Options After Eye Drug Failure - insights.citeline.com
Mizuho Downgrades KALA BIO to Neutral From Outperform, Price Target is $1.50 - MarketScreener
Kala Bio Inc Azioni (KALA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Kala Bio Inc Azioni (KALA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Former 10% owner |
Sep 30 '25 |
Sale |
1.60 |
216,801 |
345,993 |
97,120 |
| Kharabi Darius | CHIEF BUSINESS OFFICER |
Jun 24 '25 |
Sale |
4.01 |
4,511 |
18,089 |
62,566 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Jun 24 '25 |
Sale |
4.01 |
3,631 |
14,560 |
62,100 |
| Bazemore Todd | SEE REMARKS |
Jun 24 '25 |
Sale |
4.01 |
4,058 |
16,273 |
83,699 |
| Brazzell Romulus K | SEE REMARKS |
Jun 24 '25 |
Sale |
4.01 |
5,251 |
21,057 |
82,698 |
| Iwicki Mark T | Director |
Jun 24 '25 |
Sale |
4.01 |
13,227 |
53,040 |
258,433 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):